Clinical trial
Treatment of Refractory Immune Thrombocytopenia
NCT06787989 is registered in ClinicalTrials.gov with iCell Gene Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Refractory Immune Thrombocytopenia
- Lead sponsor
- iCell Gene Therapeutics
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- August 31, 2024
- Completion date
- April 30, 2027
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
refractory immune cytopenia